Comparative Efficacy and Safety of Ultra-Long-Acting, Long-Acting, Intermediate-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: a Systematic Review and Network Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative Efficacy and Safety of Ultra-Long-Acting, Long-Acting, Intermediate-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: a Systematic Review and Network Meta-Analysis
Authors
Keywords
-
Journal
JOURNAL OF GENERAL INTERNAL MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-20
DOI
10.1007/s11606-021-06642-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glycemic Management in Adults With Type 1 Diabetes
- (2018) Angela McGibbon et al. Canadian Journal of Diabetes
- Morning administration of 0.4 U/kg/day insulin glargine 300 U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100 U/mL in type 1 diabetes
- (2018) T.S. Bailey et al. DIABETES & METABOLISM
- Biosimilar vs originator insulins: Systematic review and meta-analysis
- (2018) Tomohide Yamada et al. DIABETES OBESITY & METABOLISM
- A GUIDE TO FOLLOW-ON BIOLOGICS AND BIOSIMILARS WITH A FOCUS ON INSULIN
- (2018) Richard Dolinar et al. Endocrine Practice
- Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review
- (2018) Carolyn Tieu et al. PLoS One
- Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes
- (2017) Wendy Lane et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bibliographic study showed improving statistical methodology of network meta-analyses published between 1999 and 2015
- (2017) Maria Petropoulou et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Power analysis for random-effects meta-analysis
- (2017) Dan Jackson et al. Research Synthesis Methods
- Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial
- (2017) Ryo Iga et al. Diabetes Therapy
- Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial
- (2017) Ryo Iga et al. Diabetes Therapy
- Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries
- (2016) Veronika J. Wirtz et al. CIRCULATION
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
- (2015) Brian Hutton et al. ANNALS OF INTERNAL MEDICINE
- Similar risk of exercise-related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross-over trial
- (2015) T. Heise et al. DIABETES OBESITY & METABOLISM
- Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine
- (2015) Tim Heise et al. Expert Opinion on Drug Metabolism & Toxicology
- Design, Analysis, and Reporting of Crossover Trials for Inclusion in a Meta-Analysis
- (2015) Tianjing Li et al. PLoS One
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Characteristics of Networks of Interventions: A Description of a Database of 186 Published Networks
- (2014) Adriani Nikolakopoulou et al. PLoS One
- Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report
- (2014) Jeroen P. Jansen et al. VALUE IN HEALTH
- Conceptual and Technical Challenges in Network Meta-analysis
- (2013) Andrea Cipriani et al. ANNALS OF INTERNAL MEDICINE
- Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers
- (2013) Jeroen P Jansen et al. BMC Medicine
- A Comparison of the Steady-State Pharmacokinetic and Pharmacodynamic Profiles of 100 and 200 U/mL Formulations of Ultra-Long-Acting Insulin Degludec
- (2013) Stefan Korsatko et al. CLINICAL DRUG INVESTIGATION
- Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN®Basal-Bolus Type 1): 2-year results of a randomized clinical trial
- (2013) B. W. Bode et al. DIABETIC MEDICINE
- Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study
- (2013) Gerd Koehler et al. DIABETOLOGIA
- Evaluation of inconsistency in networks of interventions
- (2013) A. A. Veroniki et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
- (2013) Chantal Mathieu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Graphical Tools for Network Meta-Analysis in STATA
- (2013) Anna Chaimani et al. PLoS One
- Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes
- (2012) T. Heise et al. DIABETES OBESITY & METABOLISM
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Simon Heller et al. LANCET
- Evidence Synthesis for Decision Making 2
- (2012) Sofia Dias et al. MEDICAL DECISION MAKING
- Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
- (2012) J. P. T. Higgins et al. Research Synthesis Methods
- Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool
- (2012) Georgia Salanti Research Synthesis Methods
- Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression
- (2012) Ian R. White et al. Research Synthesis Methods
- Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine
- (2011) K. I. Birkeland et al. DIABETES CARE
- Revisiting the efficacy of long-acting insulin analogues on adults with type 1 diabetes using mixed-treatment comparisons
- (2011) Andréia Cristina Conegero Sanches et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pauta óptima de administración de insulina detemir en sujetos diabéticos tipo 1 con mal control metabólico
- (2010) Raquel Segovia Portolés et al. Endocrinologia y Nutricion
- An evidence-based practice guideline for the peer review of electronic search strategies
- (2009) Margaret Sampson et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started